Business Context and Reporting Period
This Form 6-K is filed by Midatech Pharma PLC (noted as Biodexa Pharmaceuticals Plc in request metadata) for the month of March 2017. The filing serves to incorporate by reference a press release dated March 14, 2017, titled "Notice of Preliminary Results." The registrant is a foreign private issuer based in Abingdon, Oxfordshire, United Kingdom.
Key Financial Metrics
The provided filing text is a cover sheet and does not contain specific financial data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this document. The actual financial figures are contained within the attached Exhibit 99.1 (Press Release), which is not included in the input text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only indicates that preliminary results for the period are available in the attached press release.
Guidance, Outlook, and Risks
No management commentary, guidance, outlook, risks, contingencies, or unusual items are detailed in the cover sheet text. These elements would be found in the referenced "Notice of Preliminary Results" press release.
Investor Verification Checklist
- Verify the discrepancy between the request metadata ("Biodexa Pharmaceuticals Plc") and the filing registrant name ("Midatech Pharma PLC").
- Locate and review the full text of Exhibit 99.1 ("Notice of Preliminary Results") to obtain actual financial figures.
- Confirm the reporting period covered by the preliminary results referenced in the press release.
- Check for any subsequent filings or updates regarding the company's financial status post-March 2017.